Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (137)
- Compliance and enforcement (35)
- Import and export (35)
- Shortages and supply disruptions (17)
- Sunscreens (10)
- Advertising (7)
- COVID-19 (5)
- Labelling and packaging (5)
- Weight loss products (5)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1309 result(s) found, displaying 1201 to 1225
-
Safety alertsTGA safety alert on Vytorin outlines findings from a clinical study suggesting a possible increase in cancer deaths, noting uncertainty and advising patients to continue treatment while evidence is reviewed.
-
Market actionsThis product contains the toxic substance ethylene glycol (rather than the non-toxic ingredient propylene glycol).
-
Safety alertsRecall of Thermoskin® brand gel hot/cold packs after testing revealed that the packs contain the toxic substance ethylene glycol, rather than the non-toxic ingredient propylene glycol.
-
Market actions2008 recall of MD Lash Factor Eyelash Conditioner.
-
Market actionsClexane (enoxaparin) is being recalled due to contamination concerns, and patients should check with their doctor or pharmacist to see if their supply is affected.
-
Market actionsConsumers should stop using Clexane (enoxaparin) from the newly recalled batch due to impurity concerns. Check with your doctor or pharmacist to see if your supply is affected and return any contaminated product. If you have any concerns, consult your doctor.
-
Safety alertsThe TGA has been informed by the supplier of Clexane, sanofi-aventis Australia, that this recall applies to one batch of Clexane 80mg, with batch number 08018.
-
Safety alertsScreening guidelines for women exposed in utero to diethylstilboestrol (DES)
-
Market actionsCertain batches of Clexane (enoxaparin) have been recalled because of an impurity. Stop using it, check with your healthcare provider, and return any affected product. If you have concerns, consult your doctor.
-
-
Safety alertsTGA safety alert on heparin products highlights concerns about contamination linked to allergic‑type reactions, outlines recalls of affected batches and confirms testing to ensure remaining products are safe for use.
-
-
Market actionsContinuing Australian reporting of bizarre and sometimes dangerous sleep related behaviours such as sleep walking and sleep driving in some users of zolpidem.
-
Safety alertsInformation for health professionals and consumers about the rare risk of osteonecrosis of the jaw associated with bisphosphonate medicines, including risk factors and precautions.
-
Market actions2007 recall of Physio Care Lida Dai Dai Hua Jiao Nang Slimming Capsules.
-
Market actions2007 recall of Dymatize Nutrition Anabolic Meth-X 100 capsules.
-
Market actionsConsumer recall for VPX “No Shotgun” and BSN “Cell Mass” bodybuilding powders due to traces of the prescription drug coumarin.
-
Market actionsMicrobial contamination of the antiseptic wipes contained in the first aid kits.
-
-
Market actions2007 recall of Top Gun for Men Herbal Extracts.
-
Market actions2007 recall of VIRACEPT.
-
Market actionsThe sponsor has identified an increased number of complaints regarding the ability to resuspend Combantrin Suspension. This can give rise to dosing errors.
-
Market actionsThe company is taking this action as a precaution because of reports of a rare, but serious, eye infection, Acanthamoeba keratitis, caused by a parasite.
-
Market actionsThe products have been found to contain an analogue of sildenafil, a prescription only medicine, which could give rise to serious health consequences, especially for patients with existing medical conditions such as heart problems, or persons at risk of stroke.
-